Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone for diastolic dysfunction after heart transplantation
ACTRN12606000193572Phase 4Not yet recruiting
- Sponsor
- The Alfred Hospital
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in diastolic dysfunction and cardiac fibrosis comparing Spironolactone with Placebo (2 arms). Primary endpoint: Myocardial function. Planned start May 2006; status: not yet recruiting.
02
Drugs
spironolactone
03
Conditions
diastolic dysfunctioncardiac fibrosis
Beyond the preview
Go deeper on ACTRN12606000193572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000193572.